France Home Healthcare Market (2025-2030)
The France Home Healthcare Market was valued at $13911.05 Million in 2025 and projected to reach to $20990.71 Million by 2030, representing a compound annual growth rate of 8.6%. France's home healthcare market is positioned for sustained growth through 2030, driven by demographic pressures and evolving healthcare preferences.
France Home Healthcare Market Trends and Insights
- This 8.6% compound annual growth rate reflects France's aging population and increasing preference for in-home care services over institutional settings.
- France is capitalizing on technological advancements and government support for aging-in-place initiatives, positioning itself as a key market within Europe's home healthcare sector. The French home healthcare landscape is driven by demographic shifts, with France's elderly population requiring specialized care services.
- Between 2025 and 2030, France is expected to see significant investment in home-based medical and non-medical services, supported by favorable reimbursement policies and healthcare reforms.
- France's market growth outpaces several European peers, reflecting strong demand for personalized, cost-effective care delivery in residential settings. France's home healthcare expansion is underpinned by workforce development, digital health integration, and partnerships between public and private providers.
- As France continues to modernize its healthcare infrastructure, the home healthcare sector will play an increasingly vital role in meeting the nation's long-term care needs..
Key Market Statistics
- CAGR (2025-2030) 8.6% CAGR
- Market Size, 2025 ~USD 13911.05 Million
- Forecast, 2030 ~USD 20990.71 Million
- Country France
France Home Healthcare Market Overview
Aging Population Driving Demand :
France's demographic shift toward an older population is a primary growth catalyst. With increasing life expectancy and a rising proportion of elderly citizens preferring independent living, demand for home healthcare services continues to accelerate across the country.
Government Support & Policy Framework :
French government initiatives promoting aging-in-place policies and subsidized home care services are strengthening market expansion. Regulatory support and reimbursement mechanisms facilitate service provider growth and accessibility for French households.
Technological Integration in Care :
Digital health solutions, remote monitoring devices, and telehealth platforms are transforming France's home healthcare delivery. Technology adoption enhances service quality, reduces costs, and improves patient outcomes across urban and rural regions.
Preference Shift from Institutional Care :
French consumers increasingly favor home-based care over nursing homes and hospitals. This cultural preference, combined with cost advantages and improved quality of life, is reshaping the competitive landscape and driving market consolidation.
France Home Healthcare Market Dynamics
- The 8.6% CAGR reflects strong demand from an aging population seeking personalized, cost-effective care solutions.
- Government backing through reimbursement policies and aging-in-place initiatives creates a favorable regulatory environment for service expansion. Technological innovation will play a pivotal role in market evolution, with digital health platforms and remote monitoring becoming standard offerings.
- Market consolidation among providers is expected as larger players acquire specialized services.
- Competition will intensify around service quality, caregiver training, and integrated care models, positioning France as a key growth market within Europe's home healthcare sector..
Related Ecosystem
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- JOHNSON & JOHNSON
Key Takeaways
- France's home healthcare market will grow from USD 13.9B (2025) to USD 21.0B (2030) at an 8.6% CAGR.
- France's aging demographic and preference for aging-in-place are primary growth catalysts for home healthcare expansion.
- France's government policies and reimbursement frameworks support sustained investment in home-based care services.
- France is integrating digital health technologies and workforce development to enhance service delivery and market competitiveness.
Home Healthcare Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | INSULIN DELIVERY DEVICES (Type) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 8.9% from 2025 to 2030 |
| Largest Segment | THERAPEUTIC PRODUCTS (Product) |
| Market Size Base Year (Billions) | ~USD 309.35 (2025) |
| Revenue Forecast (Billions) | ~USD 473.8 (2030) |
| Segments Covered | Product, Type, Product & Service |
France Home Healthcare Market Report Segmentation
3 segment dimensions are covered across the global market.
By Product
- Mobility Care Products
- Testing, Screening, & Monitoring Products
- Testing, Screening, And Monitoring Products
- Therapeutic Products
By Type
- Activity Monitors & Wrist Bands
- Blood Glucose Monitors
- Blood Pressure Monitors
- Cancer
- Canes
- Cardiovascular Diseases & Hypertension
- Cardiovascular Disorders & Hypertension
- Cholesterol Testing Products
- Coagulation Monitoring Products
- Colon Cancer Test Kits
- Crutches
- Diabetes
- Dialysis Equipment
- Drug & Alcohol Test Kits
- Ecg/Ekg Devices
- Eeg Devices
- Fetal Monitoring Devices
- Hearing Aids
- Hearing Disorders
- Heart Rate Monitors
- Hiv Test Kits
- Holter & Event Monitors
- Home Hba1C Test Kits
- Home Hemoglobin A1C Test Kits
- Home Sleep Testing Devices
- Hospice & Palliative Care Services
- Hospice And Palliative Care Services
- Infusion Therapy Services
- Inhalers
- Insulin Delivery Devices
- Iv Equipment
- Mobility Disorders
- Mobility Scooters
- Nebulizers
- Other Indications
- Other Therapeutic Products
- Ovulation & Pregnancy Test Kits
- Oxygen Delivery Systems
- Peak Flow Meters
- Pregnancy
- Pregnancy Care Services
- Pulse Oximeters
- Rehabilitation Therapy Services
- Respiratory Diseases
- Respiratory Therapy Services
- Skilled Nursing Services
- Sleep Apnea Therapeutic Devices
- Temperature Monitoring Devices
- Unskilled Care Services
- Ventilators
- Walkers & Rollators
- Wheelchairs
- Wound Care
- Wound Care Products
By Product & Service
- Product
- Service
Target Audience
- Healthcare Investors & PE Firms : Evaluate investment opportunities in France's high-growth home healthcare sector. Use market sizing, CAGR data, and competitive analysis to assess portfolio companies, identify acquisition targets, and structure funding strategies.
- Home Healthcare Service Providers : Benchmark operational performance against France-specific market trends. Understand growth drivers, competitive positioning, and expansion opportunities to optimize service delivery, pricing strategies, and geographic footprint.
- Medical Device & Technology Companies : Identify product-market fit opportunities for home healthcare solutions in France. Analyze technology adoption rates, regulatory pathways, and customer segments to guide R&D investments and go-to-market strategies.
- Government & Policy Makers : Access comprehensive market data to inform healthcare policy, budget allocation, and aging-in-place initiatives. Use insights to optimize reimbursement structures and evaluate program effectiveness in France's home care ecosystem.
- Consulting & Strategy Firms : Leverage France-specific market intelligence for client advisory work. Support strategic planning, market entry analysis, and competitive positioning for healthcare organizations targeting the French home healthcare market.
Key Companies in the France Home Healthcare Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| FISHER & PAYKEL HEALTHCARE | United States | Public Company | Therapeutic (CPAP, humidification, respiratory support devices),Monitoring, Testing, Screening (OSA and respiratory-related),Mobility Care and accessories, |
| NOVO NORDISK A/S | Denmark | Public Company | Therapeutic (insulins, GLP-1, obesity and rare disease therapies used at home),Testing, Screening, Monitoring (digital dose guidance, data connectivity around pens),Mobility Care, |
| APRIA HEALTHCARE GROUP, INC | United States | Private Company | Therapeutic (respiratory, sleep apnea, NPWT, other HME),Testing, Screening, Monitoring,Mobility Care and other HME, |
| CONMED CORPORATION | United States | Public Company | Therapeutic (home-use relevant),Testing, Screening, Monitoring,Mobility Care, |
| CONSORT MEDICAL | United Kingdom | Private Company | Therapeutic (drug delivery devices for home use),Testing, Screening & Monitoring–linked devices,Mobility Care–adjacent components, |
| HENRY SCHEIN | United States | Public Company | Therapeutic products for home use,Testing, screening, and monitoring,Mobility care and durable equipment, |
| HILL-ROM HOLDINGS, INC. | United States | Private Company | Therapeutic (incl. respiratory and non-invasive therapeutic surfaces),Mobility Care (beds, lifts, patient mobility solutions for home),Testing, Screening & Monitoring, |
| JABIL | United States | Public Company | Therapeutic devices (home-use),Testing, Screening & Monitoring devices,Mobility care hardware, |
| ROSSMAX INTERNATIONAL LTD | Taiwan | Public Company | Monitoring (BP monitors, thermometers, oximeters, scales),Therapeutic & Respiratory (nebulizers, suction units, aero spacers, heating pads, anti-decubitus mattresses),Testing & Screening (blood glucose systems, peak flow meters), |
| FRESENIUS MEDICAL CARE AG | Germany | Public Company | Therapeutic (home dialysis equipment, solutions, consumables),Testing, Screening, Monitoring,Mobility Care, |
| ABBOTT | United States | Public Company | Testing, Screening, and Monitoring,Therapeutic,Mobility Care, |
| LINDE PLC | United Kingdom | Public Company | Therapeutic (home oxygen, respiratory support),Testing, Screening, Monitoring,Mobility Care, |
| RESMED | United States | Public Company | Therapeutic (home respiratory and sleep therapy devices),Testing & Screening (home sleep diagnostics),Monitoring (remote patient monitoring and analytics), |
| KONINKLIJKE PHILIPS N.V. | Netherlands | Public Company | Therapeutic (incl. sleep and respiratory care, home ventilation),Testing, Screening, Monitoring (remote patient monitoring, diagnostics at home),Mobility Care and Personal Health Devices, |
| GE HEALTHCARE | United States | Public Company | Monitoring (vital signs, diagnostic cardiology, maternal-infant),Testing, Screening & Imaging-linked Home Pathways,Therapeutic & Infusion-linked Solutions, |
| A&D HOLON HOLDINGS COMPANY, LIMITED | Japan | Public Company | Testing, Screening, and Monitoring Devices,Therapeutic Devices (Ultrasonic Inhalers),Mobility Care, |
| CONVATEC GROUP PLC | United Kingdom | Public Company | Therapeutic products (wound, ostomy, continence, infusion sets) used at home,Monitoring / testing interfaces linked to infusion and chronic care,Mobility and home-care accessories for chronic-condition management, |
| AMEDISYS | United States | Private Company | Therapeutic (home-based therapies, including infusion support),Testing, Screening, Monitoring (clinical assessments, remote oversight),Mobility Care (rehabilitation, PT/OT, functional support), |
| INVACARE CORPORATION | United States | Private Company | Mobility Care (power and manual wheelchairs, ramps),Therapeutic & Lifestyle (pressure-relief, beds, safe patient handling),Testing, Screening & Monitoring (heart rate monitors, thermometers), |
| SUNRISE MEDICAL | United States | Private Company | Mobility Care (manual & power wheelchairs, scooters),Therapeutic & Rehabilitation Products (seating, positioning),Testing, Screening, Monitoring & Other, |
FISHER & PAYKEL HEALTHCARE
Fisher & Paykel Healthcare is a publicly traded medical device company founded in 1934 and headquartered in the United States. With 7,396 employees, the company designs and manufactures healthcare products and systems.
NOVO NORDISK A/S
Novo Nordisk A/S is a Danish pharmaceutical company founded in 1923 and publicly listed on stock exchanges. The company employs 67,900 people and focuses on biopharmaceutical research and development.
APRIA HEALTHCARE GROUP, INC
Appia Healthcare Group, Inc. is a privately held U.S. healthcare company founded in 2018 with 6,250 employees. The company provides healthcare services and solutions to patients and providers.
CONMED CORPORATION
CONMED Corporation is a publicly traded medical technology company founded in 1970 and based in the United States. With 3,900 employees, the company manufactures surgical and patient monitoring equipment.
CONSORT MEDICAL
Consort Medical is a privately held British medical device company founded in 1938 with 2,000 employees. The company develops and manufactures drug delivery and diagnostic devices.
HENRY SCHEIN
Henry Schein is a publicly traded healthcare company founded in 1932 and headquartered in the United States. With 25,000 employees, the company distributes medical, dental, and veterinary products and services.
HILL-ROM HOLDINGS, INC.
Hill-Rom Holdings, Inc. is a privately held medical technology company founded in 1915 and based in the United States. The company employs 10,000 people and manufactures patient care equipment and solutions.
JABIL
Jabil is a publicly traded electronics manufacturing services company founded in 1966 with 135,000 employees. The company provides design, engineering, and manufacturing services across multiple industries including healthcare.
ROSSMAX INTERNATIONAL LTD
Rossmax International Ltd. is a publicly traded Taiwanese medical device company founded in 1988. The company manufactures and distributes healthcare monitoring and diagnostic equipment.
FRESENIUS MEDICAL CARE AG
Fresenius Medical Care AG is a publicly traded German healthcare company founded in 1996 with 108,165 employees. The company provides dialysis products, services, and healthcare solutions globally.
ABBOTT
Abbott is a publicly traded American healthcare company founded in 1888 with 115,000 employees. The company manufactures and distributes pharmaceuticals, medical devices, diagnostics, and nutritional products.
LINDE PLC
Linde PLC is a publicly traded British industrial gases and healthcare company founded in 1879 with 65,034 employees. The company supplies gases, equipment, and services to healthcare and other industries.
RESMED
ResMed is a publicly traded medical device company founded in 1989 and headquartered in the United States. With 10,600 employees, the company manufactures cloud-connected medical devices for respiratory care and patient monitoring.
KONINKLIJKE PHILIPS N.V.
Koninklijke Philips N.V. is a publicly traded Dutch technology company founded in 1891 with 64,317 employees. The company manufactures healthcare equipment, consumer electronics, and lighting solutions.
GE HEALTHCARE
GE Healthcare is a publicly traded American healthcare technology company founded in 2022 with 54,000 employees. The company provides medical imaging, monitoring, and diagnostic equipment and services.
A&D HOLON HOLDINGS COMPANY, LIMITED
A&D Holon Holdings Company, Limited is a publicly traded Japanese medical device company founded in 1977 with 2,480 employees. The company manufactures and distributes healthcare monitoring and diagnostic equipment.
CONVATEC GROUP PLC
ConvaTec Group PLC is a publicly traded British medical technology company founded in 1978 with 10,910 employees. The company manufactures ostomy care, continence care, and wound care products.
AMEDISYS
Amedisys is a privately held American healthcare company founded in 1982 with 19,000 employees. The company provides home health, hospice, and personal care services.
INVACARE CORPORATION
Invacare Corporation is a privately held American medical device company founded in 1885 with 2,800 employees. The company manufactures mobility and respiratory care products for patients.
SUNRISE MEDICAL
Sunrise Medical is a privately held American medical device company founded in 1978 with 4,470 employees. The company manufactures and distributes mobility and accessibility products for patients.
Reasons to Buy this Report
- Market Size & Growth Validation : Obtain precise market valuation data for France (USD 13.9B in 2025) with verified 8.6% CAGR projections through 2030. Make informed investment and expansion decisions backed by quantified market metrics specific to the French home healthcare sector.
- Competitive Landscape Intelligence : Understand France's unique competitive dynamics, including provider consolidation trends, market entry barriers, and key player positioning. Identify white-space opportunities and strategic partnerships tailored to the French market context.
- Regulatory & Policy Insights : Access detailed analysis of French government support mechanisms, reimbursement frameworks, and aging-in-place policies. Navigate regulatory requirements and leverage government incentives to accelerate market penetration and service adoption.
- Demographic & Consumer Trends : Leverage France-specific demographic data on aging populations, consumer preferences for home care, and cultural shifts away from institutional settings. Tailor product and service offerings to match French market demands and expectations.
- Technology & Innovation Roadmap : Identify emerging technology adoption patterns in French home healthcare, including telehealth, remote monitoring, and digital platforms. Align innovation strategies with market-ready solutions that resonate with French providers and consumers.
Frequently asked questions
What is the current size of France's home healthcare market?
France's home healthcare market is valued at USD 13,911.05 million in 2025, with expectations to reach USD 20,990.71 million by 2030.
What is the projected growth rate for France's home healthcare market?
France's home healthcare market is projected to grow at a compound annual growth rate (CAGR) of 8.6% between 2025 and 2030.
What factors are driving growth in France's home healthcare sector?
France's home healthcare growth is driven by an aging population, government support for aging-in-place policies, technological advancements, and favorable reimbursement frameworks.
How does France's home healthcare market compare to other European markets?
France's 8.6% CAGR demonstrates strong market momentum, with growth rates competitive among major European home healthcare markets, supported by robust healthcare infrastructure and demographic trends.
What role does technology play in France's home healthcare market expansion?
Digital health integration, remote monitoring systems, and telehealth platforms are increasingly adopted in France to enhance service delivery, improve patient outcomes, and optimize operational efficiency.
RESEARCH METHODOLOGY
This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, fundamental market dynamics, and key player strategies.
Secondary Research
The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, investor presentations, SEC filings of companies and publications from government sources [such as National Institutes of Health (NIH), US FDA, US Census Bureau, World Health Organization (WHO), , Global Burden of Disease Study, and Centers for Medicare and Medicaid Services (CMS) were referred to identify and collect information for the global home healthcare market study. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations in the home healthcare market. The primary sources from the demand side include home healthcare service providers and home users. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends & key market dynamics.
A breakdown of the primary respondents is provided below:
*C-level primaries include CEOs, CFOs, COOs, and VPs.
*Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
Note: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = < USD 1.00 billion.
Source: MarketsandMarkets Analysis
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
For the global market value, annual revenues were calculated based on the revenue mapping of major product manufacturers and OEMs active in the global home healthcare market. All the major service providers were identified at the global and/or country/regional level. Revenue mapping for the respective business segments/subsegments was done for the major players. Also, the global home healthcare market was split into various segments and sub-segments based on:
- List of major players operating in the product market at the regional and/or country level
- Product mapping of home healthcare providers at the regional and/or country level
- Mapping of annual revenue generated by listed major players from home healthcare (or the nearest reported business unit/product category)
- Extrapolation of the revenue mapping of the listed major players to derive the global market value of the respective segments/subsegments
- Summation of the market value of all segments/subsegments to arrive at the global home healthcare market
The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.
Market Size Estimation (Bottom-up Approach & Top-down Approach)
Data Triangulation
After arriving at the overall size of the global home healthcare market through the above-mentioned methodology, this market was split into several segments and subsegments. The data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact market value data for the key segments and subsegments. The extrapolated market data was triangulated by studying various macro indicators and regional trends from both demand- and supply-side participants.
Market Definition
Home healthcare refers to the medical attention, care, and support provided to patients at their residences by licensed healthcare workers, such as nurses, home health aides, and personal care aides. The home healthcare market includes products and services that can be set up remotely at a patient’s home.
Stakeholders
- Home Healthcare Equipment Manufacturers
- Home Healthcare Service Providers
- Home Health Software Vendors
- Nursing Service Providers
- Wound Care Product Manufacturers
- Pregnancy Care Product Manufacturers and Service Providers
- Supportive Care Product Manufacturers and Service Providers
- Diagnostic Companies
- Research & Development (R&D) Companies
- Business Research and Consulting Service Providers
- Medical Research Laboratories
- Venture Capitalists
Report Objectives
- To define, describe, segment, and forecast the global home healthcare market by product, service, indication, and region
- To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall home healthcare market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the market segments with respect to five regions: North America, Europe, the Asia Pacific, Latin America, Middle East & Africa, and GCC Countries
- To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
- To track and analyze company developments such as acquisitions, product launches & approvals, and expansions
- To benchmark players within the market using the proprietary “Competitive Leadership Mapping” framework, which analyzes market players on various parameters within the broad categories of business and product strategy
Get the Full Home Healthcare Market Report
Full forecast, segment splits, and company analysis for all Home Healthcare Market.
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report